Health Professionals Petition WHO for Guidance: People Should Use Nasal Sprays to Combat COVID-19 Pandemic; Doctors Use in Treating Patients
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
WASHINGTON -- Businesswire -- Today, a consortium of health professionals petitioned the World Health Organization to issue Guidance calling on: all people to use nasal sprays to combat the COVID-19 pandemic; doctors to use them in treating COVID-19 patients; and, Member-States to implement public health policies promoting the use of nasal sprays to both prevent and treat COVID-19.
The petition asks the WHO to promulgate guidance that promotes the use of nasal sprays with data indicating that they are antiviral (blocks viral adhesion), virucidal (kills or deactivates the virus), anti-bacterial (block bacteria, in particular pneumonia bacteria) and bactericidal (kills bacteria, in particular pneumonia bacteria).
“We have data showing that certain nasal sprays don’t just wash away the virus. Certain sprays actually block, deactivate and/or kill the virus,” said Dr. Gustavo Ferrer, a respiratory illness expert who has conducted research on the use of nasal sprays to combat COVID-19, and is among the petitioners.
As a result, the petition calls specifically for WHO Guidance to focus on the use of nasal sprays that contain Xylitol and grapefruit seed extract. Recent studies have found that these natural components used together are antiviral (they block SARS-CoV-2 adhesion to the nasal membrane) and virucidal (they kill or deactivate the virus). One such spray, Xlear, is currently widely available in the US. Xlear has been used by millions of people worldwide, over twenty-plus years, without any adverse effects reported.
Additionally, a new, small clinical study found Xlear lessens the severity and shortens the duration of COVID-19 illnesses, and reduces the risk of further transmission, which is why the petition calls for guidance to doctors to use it as an adjunct to current treatments.
“Nasal sprays are proven safe, inexpensive, non-invasive, easy to use and you can get them off-the-shelf at your local store around the world. There is a growing body of data that sprays, in particular Xlear, can help combat the COVID-19 pandemic. It’s pure commonsense,” Nathan Jones, CEO of Xlear said.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210125005242/en/
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
출처:Xlear, Inc.
보도자료 통신사 뉴스와이어(www.newswire.co.kr) 배포
Copyright (c) 코리아뉴스와이어, 무단복제 및 재배포 금지
- 기아 EV6 GT·제네시스 GV60, 독일 유력 자동차 전문지 비교평가서 종합 1·2위 - 뉴스와이어
- 동원그룹, 2023년도 하반기 신입사원 공개 채용 - 뉴스와이어
- 명품브랜드 최야성의 최야성 회장, 대한민국을 빛낸 2023 자랑스러운 인물대상 ‘올해의 한류 명
- 신한카드, 스포츠 마니아를 위한 ‘SPOTV NOW’ 제휴카드 론칭 - 뉴스와이어
- LG화학, 모로코에 LFP 양극재 공장 짓는다… 화유그룹과 양극재 소재 수직 계열화 협력 - 뉴스와이
- Kenvue to Announce Third Quarter 2023 Results on October 26, 2023 - 뉴스와이어
- 켄뷰, 10월 26일 2023년 3분기 경영실적 발표 예정 - 뉴스와이어
- GS리테일, 준법 경영시스템 강화한다… 연내 ‘ISO 37301 인증’ 획득 박차 - 뉴스와이어
- Settlement Administrator Angeion Group Announces Proposed Settlement In U.S. Dollar LIBOR-Based Instrument Class Action - 뉴스
- 합의 담당자인 Angeion Group, 미 달러 리보 연계 상품 집단 소송에서 합의 제안 발표 - 뉴스와이어